Colorectal cancer (CRC) studies reveal that excessive proliferation-induced ERS activates protective autophagy through IRE1α and PERK pathways, promoting tumor cell survival and drug resistance [49]. This evidence concerns the gene EIF2AK3 and neoplasm.